| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| N-乙酰神经氨酸脑蛋白水解物Ⅱ饮品(元) | 121,537.70 | - | 124,736.51 | 177,401.76 | 97,720.35 |
| 注射用促肝细胞生长素(元) | 23,716,106.47 | 35,910,238.48 | 17,093,731.87 | 19,128,407.11 | 11,687,070.83 |
| 注射用单磷酸阿糖腺苷(元) | 3,408,014.30 | 17,421,210.77 | 9,506,707.31 | 56,759,965.28 | 32,427,655.43 |
| 注射用脑蛋白水解物(Ⅱ)(元) | 6,016,337.26 | 9,713,639.12 | 4,987,530.86 | 17,054,730.11 | 9,096,431.06 |
| 服务收入(元) | - | 16,352,429.46 | - | - | - |
| 其他(元) | 5,320,222.89 | 4,014,186.48 | 3,086,535.21 | 4,739,411.10 | 720,446.64 |
| 营业成本(元) | |||||
| N-乙酰神经氨酸脑蛋白水解物Ⅱ饮品(元) | - | - | - | 176,487.44 | - |
| 注射用促肝细胞生长素(元) | - | 1,826,653.11 | - | 2,617,107.53 | - |
| 注射用单磷酸阿糖腺苷(元) | - | 2,201,391.74 | - | 11,698,831.11 | - |
| 注射用脑蛋白水解物(Ⅱ)(元) | - | 862,900.42 | - | 1,276,230.49 | - |
| 服务收入(元) | - | 3,672,596.43 | - | - | - |
| 其他(元) | - | 5,903,285.46 | - | 2,405,440.48 | - |
| 毛利(元) | |||||
| N-乙酰神经氨酸脑蛋白水解物Ⅱ饮品(元) | - | - | - | 914.32 | - |
| 注射用促肝细胞生长素(元) | - | 34,083,585.37 | - | 16,511,299.58 | - |
| 注射用单磷酸阿糖腺苷(元) | - | 15,219,819.03 | - | 45,061,134.17 | - |
| 注射用脑蛋白水解物(Ⅱ)(元) | - | 8,850,738.70 | - | 15,778,499.62 | - |
| 服务收入(元) | - | 12,679,833.03 | - | - | - |
| 其他(元) | - | -1,889,098.98 | - | 2,333,970.62 | - |
| 毛利率(%) | |||||
| N-乙酰神经氨酸脑蛋白水解物Ⅱ饮品(%) | - | - | - | 0.52 | - |
| 注射用促肝细胞生长素(%) | - | 94.91 | - | 86.32 | - |
| 注射用单磷酸阿糖腺苷(%) | - | 87.36 | - | 79.39 | - |
| 注射用脑蛋白水解物(Ⅱ)(%) | - | 91.12 | - | 92.52 | - |
| 服务收入(%) | - | 77.54 | - | - | - |
| 其他(%) | - | -47.06 | - | 49.25 | - |
| 收入构成(%) | |||||
| N-乙酰神经氨酸脑蛋白水解物Ⅱ饮品(%) | 0.32 | - | 0.36 | 0.18 | 0.18 |
| 注射用促肝细胞生长素(%) | 61.47 | 43.05 | 49.12 | 19.55 | 21.63 |
| 注射用单磷酸阿糖腺苷(%) | 8.83 | 20.89 | 27.32 | 58.00 | 60.02 |
| 注射用脑蛋白水解物(Ⅱ)(%) | 15.59 | 11.65 | 14.33 | 17.43 | 16.84 |
| 服务收入(%) | - | 19.60 | - | - | - |
| 其他(%) | 13.79 | 4.81 | 8.87 | 4.84 | 1.33 |
| 毛利构成(%) | |||||
| N-乙酰神经氨酸脑蛋白水解物Ⅱ饮品(%) | - | - | - | 0.00 | - |
| 注射用促肝细胞生长素(%) | - | 49.44 | - | 20.72 | - |
| 注射用单磷酸阿糖腺苷(%) | - | 22.08 | - | 56.55 | - |
| 注射用脑蛋白水解物(Ⅱ)(%) | - | 12.84 | - | 19.80 | - |
| 服务收入(%) | - | 18.39 | - | - | - |
| 其他(%) | - | -2.74 | - | 2.93 | - |